Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC-CN-NFAT1 signaling in T2DM mice.

Authors:
Dong X; Kong L; Huang L; Su Y; Li X and 4 more

Journal:
J Ginseng Res

Publication Year: 2022

DOI:
10.1016/j.jgr.2022.12.006

PMCID:
PMC10214300

PMID:
37252275

Journal Information

Full Title: J Ginseng Res

Abbreviation: J Ginseng Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that no conflicts of interest exist."

Evidence found in paper:

"This work was supported by the Major Projects of the 10.13039/501100010814Anhui Provincial Department of Education (KJ2020ZD14); the 10.13039/501100001809National Natural Science Foundation of China (81970630); and the Basic and Clinical Cooperative Research Promotion Program of 10.13039/501100002947Anhui Medical University (2019xkjT021)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025